← Current compounder rows

Current NDC auxiliary source row compounder:4435

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
69194-803
Product Ndc
69194-803
Product Ndc Digits
69194803
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
803 BUPIVACAINE HCL 0.375%, LIDOCAINE HCl 2% SYRINGE
Proprietary Name Suffix
[empty]
Nonproprietary Name
bupivacaine HCL, lidocaine HCl
Dosage Form Name
INJECTION
Route Name
RETROBULBAR
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Pine Pharmaceuticals LLC
Establishment Name
Pine Pharmaceuticals LLC
Establishment Fei
[empty]
Substance Name
BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE
Active Ingredients Info
3.75 mg/1 mL; 20 mg/1 mL
History Active Ingredients Raw
BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE
History Active Ingredients Info Raw
3.75 mg/1 mL; 20 mg/1 mL
History Dosage Raw
INJECTION
Dea Schedule
[empty]
Package Ndc Raw
69194-803-01
Package Ndc
69194-803-01
Package Ndc Digits
6919480301
Package Ndc11
69194080301
Package Description
10 mL in 1 SYRINGE (69194-803-01)
Reporting Period Raw
2024-2
Reporting Period
2024-2
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:4435
Source Row Number
4435
Source Row Hash
cfa4c52128ea8aa2cefe20ad86257f0f0b34c7bf56890ec56c8a9e0ebb20b8e9
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00

Exact raw FDA source fields#

{
    "ROUTENAME": "RETROBULBAR",
    "PRODUCTNDC": "69194-803",
    "DEASCHEDULE": "",
    "LABELERNAME": "Pine Pharmaceuticals LLC",
    "SUBSTANCENAME": "BUPIVACAINE HYDROCHLORIDE; LIDOCAINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "69194-803-01",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "803 BUPIVACAINE HCL 0.375%, LIDOCAINE HCl 2% SYRINGE",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "bupivacaine HCL, lidocaine HCl",
    "PACKAGEDESCRIPTION": "10 mL in 1 SYRINGE (69194-803-01) ",
    "ACTIVEINGREDIENTSINFO": "3.75 mg/1 mL; 20 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:4435
Source Row Number
4435
Status Scope
package
Lookup Ndc
69194-803-01
Lookup Ndc Digits
6919480301
Product Ndc
69194-803
Product Ndc Digits
69194803
Package Ndc
69194-803-01
Package Ndc Digits
6919480301
Package Ndc11
69194080301
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2024-2
Reporting Period
2024-2
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
cfa4c52128ea8aa2cefe20ad86257f0f0b34c7bf56890ec56c8a9e0ebb20b8e9
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00